The stock of Dyne Therapeutics Inc (NASDAQ:DYN) last traded at $15.87, down -31.15% from the previous session.
DYN stock price is now -41.95% away from the 50-day moving average and -51.11% away from the 200-day moving average. The market capitalization of the company currently stands at $1.62B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $46, Robert W. Baird recently initiated with Outperform rating for Dyne Therapeutics Inc (NASDAQ: DYN). On November 26, 2024, RBC Capital Mkts recently initiated its ‘Outperform’ rating on the stock quoting a target price of $45, while ‘JP Morgan’ rates the stock as ‘Neutral’
In other news, Beskrovnaya Oxana, Chief Scientific Officer sold 2,334 shares of the company’s stock on Dec 11 ’24. The stock was sold for $65,632 at an average price of $28.12. Upon completion of the transaction, the Chief Scientific Officer now directly owns 201,685 shares in the company, valued at $3.2 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 11 ’24, SVP, Head of Finance & Admin. Scalzo Richard William sold 1,455 shares of the business’s stock. A total of $40,915 was realized by selling the stock at an average price of $28.12. This leaves the insider owning 127,078 shares of the company worth $2.02 million. A total of 23.60% of the company’s stock is owned by insiders.
During the past 12 months, Dyne Therapeutics Inc has had a low of $15.22 and a high of $47.45. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 17.02, and a quick ratio of 17.02. The fifty day moving average price for DYN is $27.3402 and a two-hundred day moving average price translates $32.460476 for the stock.
The latest earnings results from Dyne Therapeutics Inc (NASDAQ: DYN) was released for 2024-09-30.
